Clinical Trial Update: An Observational Study Using Artificial Intelligence (AI) Algorithms on Electrocardiography (ECG), Point-of-care Ultrasound (POCUS), and Transthoracic Echocardiophy (TTE) to Estimate the Under-diagnosis of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Across a Diverse Range of US Health Systems.

View source ↗

Summary

An observational study sponsored by Yale University uses AI analyses of ECG, point-of-care ultrasound, and transthoracic echocardiography to estimate the under-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloid Cardiomyopathy

Snippet

Sponsor: Yale University | Conditions: Transthyretin (TTR) Amyloid Cardiomyopathy | Status: ACTIVE_NOT_RECRUITING